Publications in collaboration with researchers from Hospital de la Santa Creu i Sant Pau (9)

2016

  1. Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)

    American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584

2014

  1. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: A pooled analysis of the EXAMINATION (clinical evaluation of the xience-V stent in acute myocardial INfArcTION) and COMFORTABLE-AMI

    JACC: Cardiovascular Interventions, Vol. 7, Núm. 1, pp. 55-63

  2. Optimization in stent implantation by manual thrombus aspiration in ST-segment-elevation myocardial infarction: Findings from the EXAMINATION trial

    Circulation: Cardiovascular Interventions, Vol. 7, Núm. 3, pp. 294-300

2013

  1. Everolimus-eluting stent versus bare metal stent in proximal left anterior descending ST-elevation myocardial infarction: Insights from the EXAMINATION trial

    American Heart Journal, Vol. 166, Núm. 1

  2. In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011

    Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958

  3. Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial

    International Journal of Cardiology, Vol. 168, Núm. 3, pp. 2632-2636

2012

  1. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

    The Lancet, Vol. 380, Núm. 9852, pp. 1482-1490

2011

  1. Rationale and design of the EXAMINATION trial: A randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction

    EuroIntervention, Vol. 7, Núm. 8, pp. 977-984

2006

  1. Eficacia de la implantación del stent recubierto de rapamicina en pacientes diabéticos con vasos muy pequeños (≤2,25 mm). Subanálisis del estudio DIABETES

    Revista Espanola de Cardiologia, Vol. 59, Núm. 10, pp. 1000-1007